Tag Archives: expert

Harvard health expert makes case for everyone to wear N95 masks

A health expert from Harvard made his case Tuesday that everyone in the U.S. should wear N95 face masks in order to slow the spread of COVID-19.

Joseph G. Allen, the director of the Healthy Buildings program at the university, penned an op-ed in the Washington Post and said there’s “no reason any essential worker—and really, everyone in the country – should go without masks that filter 95%.”

BIDEN DECLINES TO TELL CHICAGO TEACHERS REFUSING TO TEACH IN-PERSON TO GO BACK TO WORK

His pitch came a day after Dr. Anthony Fauci, the top disease expert in the U.S., said in an interview that wearing two cloth masks “likely” offers more protection for the wearer.

“So if you have a physical covering with one layer, you put another layer on, it just makes common sense that it likely would be more effective. That’s the reason why you see people either double masking or doing a version of an N95.”

President Biden said Tuesday that masks are “the best defense against COVID-19” in the coming months as his administration acquires a sufficient supply of vaccine to innoculate the majority of Americans.

“The brutal truth is, it’s going to take months before we can the majority of Americans vaccinated – months,” Biden said. “In the next few months, masks, not vaccines, are the best defense against COVID-19. Experts say that wearing masks from now just until April would save 50,000 lives that otherwise would pass away if we don’t wear these masks.”

Fauci’s comment was criticized on social media. Some asked why the country wasn’t told to wear double masks earlier on in the outbreak, and others asked– with that logic– wouldn’t three masks be more effective than two?

CLICK HERE TO GET THE FOX NEWS APP

Scientists continue to learn more about the disease can be transmitted. The Wall Street Journal reported that one year into the pandemic, we know that mask-wearing and good airflow inside buildings are more effective in preventing transmission than surface cleaning.

Allen wrote that if two people wore N95s it would result in a “greater than 99% reduction in exposure.”

“Think about that for a minute. We could reduce exposure by 99 percent for what should be $1 a mask. (Prices are higher now because of the failure to produce an adequate supply.) Throw in better ventilation and some distance between people, and you have hospital-grade protections,” he wrote.

Fox News’ Thomas Barrabi contributed to this report

 

Read original article here

US Coronavirus: Now that new Covid-19 variants are circulating everyday activities are more dangerous, expert says

“We’ve seen what happens in other countries that have actually had coronavirus under relatively good control, then these variants took over and they had explosive spread of the virus, and then overwhelmed hospitals,” emergency physician Dr. Leana Wen told CNN’s Anderson Cooper.

“If there is something more contagious among us, if we thought that going to the grocery store before was relatively safe, there’s actually a higher likelihood of contracting coronavirus through those every day activities,” she said.

“Wearing an even better mask, reducing the number of times that we have to go out shopping, or in indoor crowded settings, all of that will be helpful,” Wen added.

Dr. Anthony Fauci told NBC Monday wearing two masks is likely more effective in stopping the spread of the virus.

“If you have a physical covering with one layer, you put another layer on, it just makes common sense that it likely would be more effective,” he said.

Send us your questions for President Biden’s Covid-19 team

Moderna says its vaccine protects against some variants

The good news, Fauci told CNN in a separate interview Monday, is that current Covid-19 vaccines are likely to be effective against the new variants.

“The sobering news,” he added, “(is) as you get more and more replication, you can get more and more of evolution of mutants, which means you always got to be a step ahead of it.”

Moderna said Monday its vaccine created antibodies that neutralized Covid-19 variants first found in the UK and South Africa. There are concerns the vaccine may have a somewhat decreased efficacy against the strain first spotted in South Africa, and the company is working on a booster shot aimed at fighting it.

But as Covid-19 evolves, it will be important to prove “time and time again” that vaccines provide protection against new strains, Moderna president Dr. Stephen Hoge said during a panel Monday.

“Until we’ve got this thing sort of fully suppressed and in control, and people are broadly vaccinated or seropositive and protected against it, it’s going to be an ongoing battle for the next couple of years,” he said.

Meanwhile, Johnson & Johnson’s vaccine is currently being tested in South Africa, the US and Brazil, and those results could provide insight into how well it works against emerging variants, one of its developers said. The company has said it could share its Phase 3 vaccine trial data as early as this week.

“If we see the efficacy results … it’ll give us insights not only into whether or not this vaccine candidate is effective, but it’ll also give us insights into whether or not the variants that are circulating in South Africa might be a problem for vaccines,” Dr. Dan Barouch, a Harvard Medical School professor, told CNN.

6% of the US population has gotten a Covid-19 shot

So far, about 19 million people — nearly 6% of the US population — have received at least the first dose of the Covid-19 vaccine, according to CDC data. More than 3.3 million are fully vaccinated.
The numbers are a far cry from where some officials hoped the US would be by now, but President Joe Biden said Monday he is hopeful the country could soon be administering 1.5 million vaccines daily. That’s about a 50% faster pace than the goal of a million doses per day he’s promised since before inauguration.

A White House official told CNN the administration’s official goal remains getting 100 million shots administered in the President’s first 100 days in office.

Across the country, health leaders and state officials have been working to enhance their vaccination strategies and boost the number of shots going into arms.

CVS will begin offering on-site vaccinations at more than 270 locations across 11 states in February, Dr. David Fairchild, associate chief medical officer at CVS Health, said Monday.

“We’re definitely prepared and want to play a large role in helping to get the vaccine out there,” he added. “Our internal goal is to have a capacity to perform 25 million shots a month or more.”

West Virginia Gov. Jim Justice debuted a new online pre-registration system Monday, which allows residents to pre-register to receive a vaccine. Since the system’s launch Monday morning, more than 32,000 residents had scheduled a vaccine appointment, the governor said. That will work alongside an existing hotline that residents can call and pre-register.

Illinois announced it was entering its next stage of vaccinations Monday, opening guidelines to people 65 and older and frontline essential workers including teachers, first responders and grocery workers. The governor added as more doses become available, more mass vaccination sites will open up

Chicago will target 15 “high-need communities based on the City’s COVID vulnerability index,” the mayor’s office said in a news release. The initiative will include “strike teams” that will reach to “those who may be disconnected from more traditional vaccine administration channels,” it said.

“Our city is two-thirds people of color,” Mayor Lori Lightfoot said in a news briefing. “Yet we are falling woefully behind in the number of people of color who’ve been vaccinated today.”

Lightfoot said that of the nearly 108,000 residents who have received their first vaccine dose, only 17% are Latino and about 15% are Black.

Supply still limited

But many states are still struggling with supply.

Kentucky has used about 88% of their first doses so far, Gov. Andy Beshear said Monday, and called on the federal government to send more supply.

Beshear told reporters the state reached an all-time high vaccination rate last week with more than 82,500 doses administered, but highlighted the state could be in the range of 250,000 doses weekly if the supply was there.

Colorado Gov. Jared Polis also renewed a call for more vaccines as the state continues to exhaust the supply allocated by the federal government.

“I continue to urge our federal partners and the new Biden administration in Washington to ramp up vaccine distribution right away,” Polis said in a statement. “Colorado is ready to immediately use three to four times as many vaccines as we are currently getting each week right away.”

The state has so far administered more than 458,400 shots, more than 82,600 of which are second doses.

“The sooner Colorado gets more vaccines, the quicker we can get them into arms, and the faster we can help our small businesses and economy build back stronger,” the governor said. “We’re ready and welcome renewed federal assistance to get the job done.”

CNN’s Lauren Mascarenhas, Chris Boyette, Taylor Romine, Gisela Crespo, Omar Jimenez, Amanda Sealy, Andrea Diaz, Leslie Perrot, Maggie Fox and Naomi Thomas contributed to this report.

Read original article here

US Coronavirus: ‘Healthy, young’ Americans will likely get Covid-19 vaccine in mid- to late summer, expert says

“The best way to prevent the emergence of new variants is to do all of the things we’ve been talking about for months,” infectious disease expert Dr. Celine Gounder told CNN Sunday night. “The more you let the virus spread, the more it mutates, the more variants you’ll have.”

But the US continues to add staggering numbers of cases daily and faces several major challenges when it comes to vaccines. States say they don’t have enough doses, and Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said Sunday there’s a lack of information on supply.

“I would say one of the biggest problems right now is I can’t tell you how much vaccine we have,” Walensky told Fox News. “If I can’t tell it to you, then I can’t tell it to the governors and I can’t tell it to the state health officials.”

“If they don’t know how much vaccine they’re getting, not just this week but next week and the week after, they can’t plan.”

It likely will be months from now until the vaccine is widely available to the American public, Gounder, who is also a former member of the Biden transition Covid-19 advisory board, said.

“We’re looking at probably middle of the summer, end of the summer before the average, healthy, young American has access to vaccination,” Gounder told CNN Sunday.

Send us your questions for President Biden’s Covid-19 team

US should boost its vaccination goal, expert says

But while the rollout has been slower than many experts hoped, the director of the National Institutes of Health says it is now not as bad as some are making it out to be.

“We are now averaging almost a million doses per day going into arms, and that’s a pretty good trajectory to get to where President Biden wants to,” Dr. Francis Collins told MSNBC Saturday.

Biden has previously promised to administer 100 million shots in his first 100 days in office — a goal that has been criticized by some as too modest.

“We need to do better than a million shots per day,” Dr. Jonathan Reiner, professor of medicine at George Washington University told CNN Sunday.

Most of the shots being administered currently are first doses, Reiner explained.

“But as we go forward, more and more shots every day will be the second vaccination so the number of new vaccinations is going to start to drop until we get to a point in the not too distant future where every day the shots that are given are 50% follow-up and 50% new vaccinations.”

“We need to do better. We need to vaccinate about two million people a day. That should be the goal,” Reiner added.

Agencies scaling up surveillance of variant

Meanwhile, Walensky also said Sunday the CDC and other agencies were scaling up both surveillance and studies of the new variants so that “we can monitor these variants as well as monitor” the impact they may have on vaccines.

The variant called B.1.1.7 — first identified in the UK — has already been detected in more than 20 states and, according to the CDC, is more easily transmissible. Dr. Anthony Fauci said it’s possible it could also be more harmful.

“We need to assume now that what has been circulating dominantly in the UK does have a certain degree of increase in what we call virulence, namely the power of the virus to cause more damage including death,” Fauci told CBS Sunday.

Studies so far suggest vaccines will protect against the B.1.1.7 variant. But at least two studies have found another variant — first spotted in South Africa — could pose a problem for vaccines.

That variant has so far not been detected in the US, but “we need to expand greatly our genomic surveillance,” Fauci said.

“We know that it had not been at the level that we would have liked, but there’s a lot of movement right now at the CDC level, including some input from the NIH and other organizations, to dramatically increase the what we call genomic surveillance.”

‘We’ve got to be ready’ for more virus changes

For many experts, the variants are concerning but not surprising.

The larger lesson to be learned is that the virus is going to continue changing — and the US needs to be ready for that, Dr. Vivek Murthy, Biden’s nominee for US Surgeon General, told ABC Sunday.

“We’re in a race against these variants, the viruses interchange and it’s up to us to adapt and to make sure that we’re staying ahead,” he said.

Murthy said this means there must be much better surveillance so that variants can be identified when they arise, that public health measures must be doubled down on and that there should be greater investment in treatment strategies.

“Above all, this means we’ve got to invest a lot more in testing and in contact tracing, because there also are going to be essential,” Murthy added.

CNN’s Naomi Thomas and Lauren Mascarenhas contributed to this report.

Read original article here